Usability of an AI for M923 in Subjects With Moderate to Severe RA
Clinical trial NCT02722044 · COMPLETED
Trial details
- NCT number
- NCT02722044
- Sponsor
- Momenta Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-01
- Primary completion
- 2017-02-21
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.